x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Lung Cancer Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

science medicine

All Episodes

60:11

The Implications of Recent Datasets for the Current...

Lung Cancer Update ·

2024/11/25

Dr Suresh S Ramalingam from the Emory University School of Medicine in Atlanta, Georgia   and Dr Gregory J Riely from Memorial Sloan Kettering Cancer Center in New York, New York discuss the implications of recent data sets for the current and future management of lung cancer.

en

65:42

Data + Perspectives: Clinical Investigators Explore...

Lung Cancer Update ·

2024/11/16

Specialist clinical investigators share their perspectives on the evolving therapeutic landscape for patients with lung cancer.

en

54:39

Oncology Today with Dr Neil Love: Special Edition —...

Lung Cancer Update ·

2024/11/07

Dr Stephen V Liu from Georgetown University Hospital in Washington, DC, reviews recently presented data with and newly approved therapies for localized and advanced lung cancers.

en

42:46

The Implications of Recent Datasets for the Current...

Lung Cancer Update ·

2024/10/23

Dr Jacob Sands from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent presentations on approved and investigational therapies in small cell lung cancer from the 2024 World Conference on Lung Cancer.

en

60:07

The Implications of Recent Datasets for the Current...

Lung Cancer Update ·

2024/10/16

Dr Edward Garon from UCLA Health Jonsson Comprehensive Cancer Center and Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid share their perspectives on recent datasets from the 2024 World Conference on Lung Cancer on the management of non-small cell lung cancer without actionable genomic alterations.

en

58:13

The Implications of Recent Datasets for the Current...

Lung Cancer Update ·

2024/10/08

Dr Ibiayi Dagogo-Jack from Massachusetts General Hospital in Boston and Dr Corey J Langer from the Abramson Cancer Center in Philadelphia, Pennsylvania, discuss the implications of recent datasets for the current and future management of non-small cell lung cancer with actionable targets beyond EGFR.

en

58:19

The Implications of Recent Datasets for the Current...

Lung Cancer Update ·

2024/10/02

Dr Joshua K Sabari from the NYU Langone Health Perlmutter Cancer Center and Dr Helena Yu from Memorial Sloan Kettering Cancer Center in New York, New York, summarize the treatment landscape for non-small cell lung cancer with EGFR mutations.

en

59:19

Inside the Issue: Optimizing the Diagnosis and...

Lung Cancer Update ·

2024/09/19

Dr Pamela Kunz from the Yale School of Medicine and Yale Cancer Center in New Haven, Connecticut, and Dr Simron Singh from the Odette Cancer Centre and Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada, discuss optimizing the diagnosis and treatment of neuroendocrine tumors.

en

123:22

Striving for Consensus: Current and Future Management...

Lung Cancer Update ·

2024/09/12

Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbourne, Australia, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, Massachusetts, and Dr Alexander Spira from the Virginia Cancer Specialists Research Program in Fairfax, discuss recent updates on available and emerging treatment strategies for non-small cell lung cancer with an EGFR mutation.

en

61:23

Inside the Issue: Integrating ALK-Targeted Therapy...

Lung Cancer Update ·

2024/08/21

Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cancer Centre in Melbourne, Australia, discuss treatment approaches for ALK-rearranged non-small cell lung cancer in the localized disease setting.

en

61:43

Oncology Today with Dr Neil Love: Novel Agents and...

Lung Cancer Update ·

2024/08/14

Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, Dr Ticiana Leal from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr Manish Patel from Florida Cancer Specialists & Research Institute in Sarasota, Florida, summarize recently presented advancements, including novel strategies, in the treatment of lung cancer.

en

60:53

Year in Review: Clinical Investigator Perspectives on...

Lung Cancer Update ·

2024/08/05

Dr Matthew Gubens from the University of California, San Francisco summarizes important 2023 datasets guiding the use of immunotherapy and other nontargeted approaches for patients with NSCLC and no actionable mutations.

en

47:34

Oncology Today with Dr Neil Love: An interview with...

Lung Cancer Update ·

2024/07/25

Dr Jonathan W Goldman from UCLA Health in Santa Monica, California summarizes recent developments presented at ASCO 2024 for patients with non-small cell lung cancer with an EGFR mutation.

en

60:48

Year in Review: Clinical Investigator Perspectives on...

Lung Cancer Update ·

2024/06/12

Dr Justin F Gainor from Massachusetts General Hospital in Boston and Dr Karen Reckamp from Cedars-Sinai Center in Los Angeles, California, summarize recently presented data on targeted therapy strategies for non-small cell lung cancer harboring actionable therapeutic targets.

en

32:24

Oncology Today with Dr Neil Love: The Emerging Role...

Lung Cancer Update ·

2024/04/04

Dr Manish Patel from the Florida Cancer Specialists & Research Institute in Sarasota, Florida, discusses drug development, early-phase clinical trials and the emerging field of B7-H3-targeted antibody-drug conjugates for solid tumors.

en

62:57

Oncology Today with Dr Neil Love: Promising...

Lung Cancer Update ·

2024/03/20

Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data with antibody-drug conjugates with established and investigational targets in patients with non-small cell lung cancer.

en

90:16

Implications of Recent Data Sets for the Current and...

Lung Cancer Update ·

2023/12/11

Dr Luis Paz-Ares from the National Oncology Research Center in Madrid, Spain, Dr Zofia Piotrowska from Massachusetts General Hospital in Boston, and Dr David R Spigel from the Sarah Cannon Research Institute in Nashville, Tennessee, discuss key presentations from the 2023 ESMO Congress for the management of lung cancer.

en

61:39

Inside the Issue: Integrating Targeted and...

Lung Cancer Update ·

2023/10/16

Dr Jamie Chaft and Dr John Heymach discuss the optimal integration of targeted therapy and immunotherapy into the care of patients with localized non-small cell lung cancer.

en

163:37

Striving for Consensus: Current and Future Management...

Lung Cancer Update ·

2023/09/08

Dr Corey Langer, Dr Ticiana Leal, Dr Karen Reckamp and Dr Jacob Sands discuss the optimal current management of relapsed NSCLC and provide perspectives on the future of care for patients with this disease.

en

32:15

Oncology Today with Dr Neil Love: Special Edition —...

Lung Cancer Update ·

2023/08/22

Featuring a discussion on key presentations on lung cancer from the 2023 ASCO Annual Meeting, with Dr Matthew Gubens, moderated by Dr Neil Love.

en

375 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter